Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001125345-25-000013
Filing Date
2025-02-11
Accepted
2025-02-11 20:20:47
Documents
3
Period of Report
2025-02-07

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1739323240.html 4  
1 FORM 4 wk-form4_1739323240.xml 4 11243
2 EX-24 tspitznagelpoa2025.htm EX-24 620
3 tspitznagelpoa2025001.jpg GRAPHIC 277212
  Complete submission text file 0001125345-25-000013.txt   395164
Mailing Address 9704 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9704 MEDICAL CENTER DRIVE Rockville MD 20850 301-251-5172
MACROGENICS INC (Issuer) CIK: 0001125345 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 9704 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address
Spitznagel Thomas (Reporting) CIK: 0001675464 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36112 | Film No.: 25611538